1 In order to elucidate the mechanisms by which 18-adrenoceptor blockade leads to a reduction in portal pressure, we have measured portal pressure, heart rate and cardiac index in 17 patients with cirrhosis and portal hypertension following the oral administration of the selective ,82-adrenoceptor blocking agent, ICI 118551, in the two dosage ranges 10-20 mg and 50-100 mg. 2 There was a fall in portal pressure in 14 of the 17 patients from a median of 17 mm Hg to a median of 15 mm Hg, P < 0.01, that occurred only at 60 min following administration of the drug. 3 Although there were early systemic haemodynamic changes, with a significant fall in heart rate and cardiac index from before to 30 min after the ingestion of ICI 118551 (median heart rates 86 and 80 beats/min respectively, P < 0.01, median cardiac indices 3.5 and 3.3 1 min-' m-2, P < 0.05), these occurred before the fall in portal pressure and were unrelated to changes in portal pressure. 4 This reduction in portal pressure independent of systemic haemodynamic changes is consistent with 132-adrenoceptor blockade within the splanchnic and hepatic arterial circulations; subsequent increases in splanchnic and hepatic arterial resistances with a concomitant fall in portal blood flow and hepatic portal resistance may lead to the reduction in portal pressure.